(Q50938438)

25 March 2018

title

Mitotic percentage index: a new prognostic factor for childhood medulloblastoma. (English)

1 reference

25 March 2018

0 references

Gilbertson RJ

1

1 reference

25 March 2018

Jaros E

2

1 reference

25 March 2018

Perry RH

3

1 reference

25 March 2018

Kelly PJ

4

1 reference

25 March 2018

Lunec J

5

1 reference

25 March 2018

Pearson AD

6

1 reference

25 March 2018

publication date

1 April 1997

1 reference

25 March 2018

European Journal of Cancer

published in

1 reference

25 March 2018

volume

33

1 reference

25 March 2018

page(s)

609-615

1 reference

25 March 2018

issue

4

1 reference

25 March 2018

The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900516-3

7 January 2021

Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO): SIOP II.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900516-3

7 January 2021

Posterior fossa medulloblastoma in childhood: treatment results and a proposal for a new staging system.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900516-3

7 January 2021

Prognostic factors in medulloblastoma, including DNA ploidy.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900516-3

7 January 2021

Radiation treatment for medulloblastoma. A 21-year review

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900516-3

7 January 2021

Low-dose craniospinal radiation therapy for medulloblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900516-3

7 January 2021

Medulloblastoma--caution regarding new treatment approaches.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900516-3

7 January 2021

Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900516-3

7 January 2021

Medulloblastoma and other primary malignant neuroectodermal tumors of the CNS. The effect of patients' age and extent of disease on prognosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900516-3

7 January 2021

Medulloblastoma. The identification of prognostic subgroups and implications for multimodality management

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900516-3

7 January 2021

A review of the factors influencing the prognosis of medulloblastoma. The importance of cell differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900516-3

7 January 2021

Prognosis of ovarian carcinomas: prediction by histoquantitative methods

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900516-3

7 January 2021

Volume-corrected mitotic index in human pancreatic cancer. Relation to histologic grade, clinical stage, and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900516-3

7 January 2021

Grading of superficial bladder cancer by quantitative mitotic frequency analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900516-3

7 January 2021

Flow cytometry, cellular DNA content, and prognosis in human malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900516-3

7 January 2021

Mitosis counting--a need for reappraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900516-3

7 January 2021

Mitosis counting in tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900516-3

7 January 2021

Assessment of inherent fluctuations of mitotic and labelling indices of human tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900516-3

7 January 2021

DNA content and other prognostic features in childhood medulloblastoma. Proposal of a scoring system

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900516-3

7 January 2021

Ploidy and proliferative index in medulloblastoma: useful prognostic factors?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900516-3

7 January 2021

DNA ploidy and proliferative activity (S-phase) in childhood soft-tissue sarcomas: their value as prognostic indicators

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900516-3

7 January 2021

Prognostic significance of the c-erbB-2 oncogene product in childhood medulloblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900516-3

7 January 2021

An intensive multiagent chemotherapy regimen for brain tumours occurring in very young children

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900516-3

7 January 2021

An operative staging system and a megavoltage radiotherapeutic technic for cerebellar medulloblastomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900516-3

7 January 2021

Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900516-3

7 January 2021

An investigation of different methods of cell cycle analysis by flow cytometry in rectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2896%2900516-3

7 January 2021

10.1016/S0959-8049(96)00516-3

Identifiers

DOI

1 reference

25 March 2018

PubMed ID

9274443

1 reference

25 March 2018